290 related articles for article (PubMed ID: 16002283)
1. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
2. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture.
Zouhiri F; Mouscadet JF; Mekouar K; Desmaële D; Savouré D; Leh H; Subra F; Le Bret M; Auclair C; d'Angelo J
J Med Chem; 2000 Apr; 43(8):1533-40. PubMed ID: 10780910
[TBL] [Abstract][Full Text] [Related]
5. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
Singh SB; Ondeyka JG; Schleif WA; Felock P; Hazuda DJ
J Nat Prod; 2003 Oct; 66(10):1338-44. PubMed ID: 14575434
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel acyclic versions of Neplanocin A.
Wu Y; Hong JH
Arch Pharm (Weinheim); 2005 Nov; 338(11):517-21. PubMed ID: 16281309
[TBL] [Abstract][Full Text] [Related]
10. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
[TBL] [Abstract][Full Text] [Related]
11. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
12. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
Elgemeie GE; Mansour OA; Metwally NH
Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
16. X-ray and molecular modelling in fragment-based design of three small quinoline scaffolds for HIV integrase inhibitors.
Majerz-Maniecka K; Musiol R; Skórska-Stania A; Tabak D; Mazur P; Oleksyn BJ; Polanski J
Bioorg Med Chem; 2011 Mar; 19(5):1606-12. PubMed ID: 21316973
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
[TBL] [Abstract][Full Text] [Related]
18. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
[TBL] [Abstract][Full Text] [Related]
19. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
Li X; Vince R
Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
